Model-informed prediction of human pharmacokinetics and first-in-human dose selection of J2H-1702, a novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor for metabolic-associated steatohepatitis
2026 · European Journal of Pharmaceutical Sciences · 0 citations
https://doi.org/10.1016/j.ejps.2026.107470